Used Selecta Trio for Sale in Tennessee
Nashville glaucoma practices run Selecta Trio for SLT treatment as the metro's ophthalmology market continues to grow. Tennessee pricing runs about 5% below baseline.
Tennessee units run 5% below baseline: $19,000–$38,000.
Selecta Trio - Key specifications
- SLT laser
- 532nm
- glaucoma
Pricing in Tennessee
Selecta Trio vs alternatives
| Model | Brand | Used Price | Key Spec |
|---|---|---|---|
| Selecta Trio ✓ | Lumenis | $20,000–$40,000 | SLT laser, 532nm, glaucoma... |
| WaveLight EX500 | Alcon | $80,000–$160,000 | Excimer laser, LASIK, 500 Hz... |
| MEL 90 | Zeiss | $70,000–$140,000 | Excimer laser, LASIK/PRK, 250 Hz... |
| Visx Star S4 IR | Abbott | $40,000–$80,000 | Excimer LASIK, iris registration... |
Active buyers in Tennessee
Facilities in Tennessee currently using or sourcing Selecta Trio:
- Vanderbilt University Medical Center, Nashville
- TriStar Centennial Medical Center, Nashville
- Saint Thomas Hospital, Nashville
- University of Tennessee Medical Center, Knoxville
- Le Bonheur Children's Hospital, Memphis
Clinical experts on Selecta Trio
- Dr. Eric Donnenfeld - Ophthalmic Consultants of Long Island. 500+ publications, FDA investigator for VISX and Alcon LASIK platforms.
- Dr. Majid Moshirfar - University of Utah, Salt Lake City. 200+ publications on refractive surgery outcomes.
FAQ - Selecta Trio in Tennessee
Is Selecta Trio common among Nashville's growing glaucoma treatment market?
Yes - as Nashville's ophthalmology market has expanded, SLT platforms like Selecta Trio have become standard equipment for glaucoma-focused practices.
What is the price of used Selecta Trio in Tennessee?
Tennessee units run 5% below baseline: $19,000–$38,000. Price depends on hours, condition grade, and included accessories.
Does TechCosmetic ship Selecta Trio to Tennessee?
Yes. We ship to all 50 states including Tennessee. Freight quotes within 24 hours, coordinated with local riggers in major Tennessee cities.
More on Selecta Trio
Similar equipment
Zero buyer commission · 2-hour response